General News

BCI at the 60th ASH Annual Meeting

Posted in General News, BCI on the Road Published by Bethan Warman 14 January 2019

‘The premier event in malignant and non-malignant haematology’

BCI at the 60th ASH Annual Meeting

Researchers from our Centre for Haemato-Oncology attended the 60th American Society of Hematology (ASH) Annual Meeting and Exposition, which took place in San Diego on 1st-4th December 2018. The ASH Annual Meeting provides an invaluable opportunity to showcase the work being conducted here at the BCI and brings together professionals from all subspecialties of blood disease research.

Globalisation of technology-enhanced learning for surgical education

Posted in General News, BCI on the Road Published by Bethan Warman 11 January 2019

Globalisation of technology-enhanced learning for surgical education

Mr Patel is a leading expert in developing higher education degrees for acquiring surgical skills by simulation. Mr Patel and his colleague, Professor Shafi Ahmed were invited to Bolivia to visit Universidad de Aquino Bolivia to discuss the use of technology-enhanced learning for surgical education as preparations were made for the launch of Bolivia’s first digital hospital.

Congratulations to the Class of 2018

Posted in General News Published by Bethan Warman 21 December 2018

Congratulations to the Class of 2018

On 17th December, the Graduation Ceremony for Queen Mary University of London’s School of Medicine and Dentistry took place. A total of 41 MSc students and 3 PhD students who studied at the BCI attended the ceremony, with almost 50% of the MSc students graduating with a distinction. Daniel Muliaditan, a student who studied the MSc Cancer & Molecular and Cellular Biology course here at the BCI, was awarded a Drapers’ Company Postgraduate Prize at the ceremony for his exceptional academic achievements.

Genomics project reaches goal of 100,000 genomes sequenced from NHS patients

Posted in General News Published by Administrator 06 December 2018

Genomics project reaches goal of 100,000 genomes sequenced from NHS patients

UK Health Secretary Matt Hancock announced yesterday that a project involving Queen Mary University of London researchers has reached its goal of sequencing 100,000 whole genomes from NHS patients. The 100,000 Genomes Project, led by Genomics England in partnership with NHS England, is a ground-breaking programme which has been based at Queen Mary’s Charterhouse Square campus since 2013, involving 24 of its staff members.

Tackling the deadliest cancer type

Posted in General News Published by Bethan Warman 30 November 2018

Our lung cancer research

Tackling the deadliest cancer type

This month is Lung Cancer Awareness Month. Lung cancer is the third most common cancer in the UK, with 46,700 new cases diagnosed each year. Approximately 35,600 people lose their lives annually as a result of lung cancer in the UK, making it the most common cause of cancer-related mortality. Only 5% of those affected survive their cancer for 10 years or more in the UK, and this survival rate has not shown much improvement over the last four decades.

Pancreatic Cancer Awareness Month 2018

Posted in General News Published by Bethan Warman 23 November 2018

Pancreatic Cancer Awareness Month 2018

November marks Pancreatic Cancer Awareness Month. Pancreatic cancer is diagnosed in over 9,900 people in the UK annually. Sadly, 90% of the individuals affected lose their lives each year, and less than 1% of patients survive the disease for 10 or more years. In the early stages of the disease, pancreatic cancer often does not show any symptoms, making timely diagnosis and intervention difficult.

‘The neighbouring effect’: Centrosomal abnormalities drive invasion of surrounding cells

Posted in General News, Publications Published by Bethan Warman 19 November 2018

‘The neighbouring effect’: Centrosomal abnormalities drive invasion of surrounding cells

Centrosomal amplification, a particular change that occurs within some cancer cells, has been shown to drive the invasion of neighbouring cancer cells in a recent study by researchers from the BCI, led by Dr Susana Godinho, and the Francis Crick Institute.

BCI welcomes two new Group Leaders

Posted in General News Published by Bethan Warman 07 November 2018

BCI welcomes two new Group Leaders

We are pleased to welcome two new members of academic staff to the BCI- Professor Victoria Sanz-Moreno, joining us from King’s College, London, and Professor Kamil R Kranc, joining us from the University of Edinburgh.

Killer cell immunotherapy shows promise for advanced pancreatic cancer

Posted in General News, Publications Published by Bethan Warman 01 November 2018

Killer cell immunotherapy shows promise for advanced pancreatic cancer

A new approach to treating pancreatic cancer using 'educated killer cells' has shown promise, according to early research from the BCI. The new cell-based immunotherapy, which has not yet been tested in humans with pancreatic cancer, led to mice being completely cancer-free.

New phase 3 clinical trial using combination therapy extends survival in triple-negative breast cancer

Posted in General News, BCI on the Road, Publications Published by Bethan Warman 22 October 2018

New phase 3 clinical trial using combination therapy extends survival in triple-negative breast cancer

New research led by Barts Cancer Institute and St Bartholomew’s Hospital has provided new hope for people with an aggressive type of breast cancer. The phase 3 clinical trial has shown that by using a combination of immunotherapy and chemotherapy, the body’s own immune system can be tuned to attack triple-negative breast cancer, extending survival by up to ten months.

[12 3 4 5  >>  
This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.